• Founded in

    2022

  • Team Size

    25

  • Company Industry

    B2B space

  • Headquarters

    Lewes, Delaware

About us

Covvalent: Innovating the $800B Specialty Chemicals Industry

Revolutionizing specialty chemicals, Covvalent is a cloud manufacturer committed to relentless innovation and strategic development.

🚀 Innovation at Scale: Targeting at-risk specialty chemicals/raw materials across FMCG, AgroChemicals, Paints, Inks & Coatings, and pharmaceuticals, we establish alternative sources for seamless supply continuity.

🔬 R&D Excellence: Our in-house Research and Development powerhouse cultivates equivalent products, reducing reliance on single sources and setting new benchmarks for quality and performance.

🤝 Expert-Led Team: Led by ex-consultants, engineering leads, and seasoned operators from Harvard Business School, IIT, and IIM, our 50+ years of cumulative experience chart the course for success.

💼 Strategic Backing: Backed by Nexus Venture Partner and influential angels in the B2B and specialty chemicals space, Covvalent is committed to industry evolution.

🌐 Global Presence: Headquartered in the US with five offices across the US and India, Covvalent ensures a global impact, connecting seamlessly with partners worldwide.

Join Covvalent on this journey where innovation meets excellence.

  • Funding Round/Series

    Seed Round

  • Funding Amount

    $4.3M

  • Latest Funding Date

    November, 2022

  • Investors

    Nexus Venture Partners, Arc180

  • Covvalent has raised a total funding of $4.3M over 1 round.
  • Covvalent has 2 institutional investors including Nexus Venture Partners and Arc180Ramakant Sharma and 6 others are Angel Investors in Covvalent.